The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Devices for Inhaled Medications-Global Market Insights and Sales Trends 2025

Devices for Inhaled Medications-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1814333

No of Pages : 120

Ask Your Query
Synopsis
The global Devices for Inhaled Medications market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Devices for Inhaled Medications in various end use industries. The expanding demands from the Clinic, Hospital and Household,, are propelling Devices for Inhaled Medications market. Dry Powder Inhalers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Metered-Dose Inhalers segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Devices for Inhaled Medications, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Devices for Inhaled Medications market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Devices for Inhaled Medications market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Devices for Inhaled Medications sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Devices for Inhaled Medications covered in this report include Consort Medical, Inhalexper, Cambridge Consultants, Hovione, Catalent, Inc, VertMarkets, Inc, Qualicaps, 3M and Aerovance, etc.
The global Devices for Inhaled Medications market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Consort Medical
Inhalexper
Cambridge Consultants
Hovione
Catalent, Inc
VertMarkets, Inc
Qualicaps
3M
Aerovance
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
Civitas/Alkermes
GlaxoSmithKline
Hovione
Mannkind
Mantecorp
Meda
MicroDose Therapeutx
Novartis
Global Devices for Inhaled Medications market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Devices for Inhaled Medications market, Segment by Type:
Dry Powder Inhalers
Metered-Dose Inhalers
Nebulizers
Soft Mist Inhaler
Global Devices for Inhaled Medications market, by Application
Clinic
Hospital
Household
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Devices for Inhaled Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Devices for Inhaled Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Devices for Inhaled Medications Market Overview
1.1 Devices for Inhaled Medications Product Overview
1.2 Devices for Inhaled Medications Market Segment by Type
1.2.1 Dry Powder Inhalers
1.2.2 Metered-Dose Inhalers
1.2.3 Nebulizers
1.2.4 Soft Mist Inhaler
1.3 Global Devices for Inhaled Medications Market Size by Type
1.3.1 Global Devices for Inhaled Medications Market Size Overview by Type (2018-2029)
1.3.2 Global Devices for Inhaled Medications Historic Market Size Review by Type (2018-2023)
1.3.3 Global Devices for Inhaled Medications Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Devices for Inhaled Medications Sales Breakdown by Type (2018-2023)
1.4.2 Europe Devices for Inhaled Medications Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Devices for Inhaled Medications Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Devices for Inhaled Medications Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Devices for Inhaled Medications Sales Breakdown by Type (2018-2023)
2 Global Devices for Inhaled Medications Market Competition by Company
2.1 Global Top Players by Devices for Inhaled Medications Sales (2018-2023)
2.2 Global Top Players by Devices for Inhaled Medications Revenue (2018-2023)
2.3 Global Top Players by Devices for Inhaled Medications Price (2018-2023)
2.4 Global Top Manufacturers Devices for Inhaled Medications Manufacturing Base Distribution, Sales Area, Product Type
2.5 Devices for Inhaled Medications Market Competitive Situation and Trends
2.5.1 Devices for Inhaled Medications Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Devices for Inhaled Medications Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Devices for Inhaled Medications as of 2022)
2.7 Date of Key Manufacturers Enter into Devices for Inhaled Medications Market
2.8 Key Manufacturers Devices for Inhaled Medications Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Devices for Inhaled Medications Status and Outlook by Region
3.1 Global Devices for Inhaled Medications Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Devices for Inhaled Medications Historic Market Size by Region
3.2.1 Global Devices for Inhaled Medications Sales in Volume by Region (2018-2023)
3.2.2 Global Devices for Inhaled Medications Sales in Value by Region (2018-2023)
3.2.3 Global Devices for Inhaled Medications Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Devices for Inhaled Medications Forecasted Market Size by Region
3.3.1 Global Devices for Inhaled Medications Sales in Volume by Region (2024-2029)
3.3.2 Global Devices for Inhaled Medications Sales in Value by Region (2024-2029)
3.3.3 Global Devices for Inhaled Medications Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Devices for Inhaled Medications by Application
4.1 Devices for Inhaled Medications Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Household
4.2 Global Devices for Inhaled Medications Market Size by Application
4.2.1 Global Devices for Inhaled Medications Market Size Overview by Application (2018-2029)
4.2.2 Global Devices for Inhaled Medications Historic Market Size Review by Application (2018-2023)
4.2.3 Global Devices for Inhaled Medications Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Devices for Inhaled Medications Sales Breakdown by Application (2018-2023)
4.3.2 Europe Devices for Inhaled Medications Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Devices for Inhaled Medications Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Devices for Inhaled Medications Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Devices for Inhaled Medications Sales Breakdown by Application (2018-2023)
5 North America Devices for Inhaled Medications by Country
5.1 North America Devices for Inhaled Medications Historic Market Size by Country
5.1.1 North America Devices for Inhaled Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Devices for Inhaled Medications Sales in Volume by Country (2018-2023)
5.1.3 North America Devices for Inhaled Medications Sales in Value by Country (2018-2023)
5.2 North America Devices for Inhaled Medications Forecasted Market Size by Country
5.2.1 North America Devices for Inhaled Medications Sales in Volume by Country (2024-2029)
5.2.2 North America Devices for Inhaled Medications Sales in Value by Country (2024-2029)
6 Europe Devices for Inhaled Medications by Country
6.1 Europe Devices for Inhaled Medications Historic Market Size by Country
6.1.1 Europe Devices for Inhaled Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Devices for Inhaled Medications Sales in Volume by Country (2018-2023)
6.1.3 Europe Devices for Inhaled Medications Sales in Value by Country (2018-2023)
6.2 Europe Devices for Inhaled Medications Forecasted Market Size by Country
6.2.1 Europe Devices for Inhaled Medications Sales in Volume by Country (2024-2029)
6.2.2 Europe Devices for Inhaled Medications Sales in Value by Country (2024-2029)
7 Asia-Pacific Devices for Inhaled Medications by Region
7.1 Asia-Pacific Devices for Inhaled Medications Historic Market Size by Region
7.1.1 Asia-Pacific Devices for Inhaled Medications Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Devices for Inhaled Medications Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Devices for Inhaled Medications Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Devices for Inhaled Medications Forecasted Market Size by Region
7.2.1 Asia-Pacific Devices for Inhaled Medications Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Devices for Inhaled Medications Sales in Value by Region (2024-2029)
8 Latin America Devices for Inhaled Medications by Country
8.1 Latin America Devices for Inhaled Medications Historic Market Size by Country
8.1.1 Latin America Devices for Inhaled Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Devices for Inhaled Medications Sales in Volume by Country (2018-2023)
8.1.3 Latin America Devices for Inhaled Medications Sales in Value by Country (2018-2023)
8.2 Latin America Devices for Inhaled Medications Forecasted Market Size by Country
8.2.1 Latin America Devices for Inhaled Medications Sales in Volume by Country (2024-2029)
8.2.2 Latin America Devices for Inhaled Medications Sales in Value by Country (2024-2029)
9 Middle East and Africa Devices for Inhaled Medications by Country
9.1 Middle East and Africa Devices for Inhaled Medications Historic Market Size by Country
9.1.1 Middle East and Africa Devices for Inhaled Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Devices for Inhaled Medications Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Devices for Inhaled Medications Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Devices for Inhaled Medications Forecasted Market Size by Country
9.2.1 Middle East and Africa Devices for Inhaled Medications Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Devices for Inhaled Medications Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Consort Medical
10.1.1 Consort Medical Company Information
10.1.2 Consort Medical Introduction and Business Overview
10.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Consort Medical Devices for Inhaled Medications Products Offered
10.1.5 Consort Medical Recent Development
10.2 Inhalexper
10.2.1 Inhalexper Company Information
10.2.2 Inhalexper Introduction and Business Overview
10.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Inhalexper Devices for Inhaled Medications Products Offered
10.2.5 Inhalexper Recent Development
10.3 Cambridge Consultants
10.3.1 Cambridge Consultants Company Information
10.3.2 Cambridge Consultants Introduction and Business Overview
10.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cambridge Consultants Devices for Inhaled Medications Products Offered
10.3.5 Cambridge Consultants Recent Development
10.4 Hovione
10.4.1 Hovione Company Information
10.4.2 Hovione Introduction and Business Overview
10.4.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hovione Devices for Inhaled Medications Products Offered
10.4.5 Hovione Recent Development
10.5 Catalent, Inc
10.5.1 Catalent, Inc Company Information
10.5.2 Catalent, Inc Introduction and Business Overview
10.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Catalent, Inc Devices for Inhaled Medications Products Offered
10.5.5 Catalent, Inc Recent Development
10.6 VertMarkets, Inc
10.6.1 VertMarkets, Inc Company Information
10.6.2 VertMarkets, Inc Introduction and Business Overview
10.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.6.4 VertMarkets, Inc Devices for Inhaled Medications Products Offered
10.6.5 VertMarkets, Inc Recent Development
10.7 Qualicaps
10.7.1 Qualicaps Company Information
10.7.2 Qualicaps Introduction and Business Overview
10.7.3 Qualicaps Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Qualicaps Devices for Inhaled Medications Products Offered
10.7.5 Qualicaps Recent Development
10.8 3M
10.8.1 3M Company Information
10.8.2 3M Introduction and Business Overview
10.8.3 3M Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.8.4 3M Devices for Inhaled Medications Products Offered
10.8.5 3M Recent Development
10.9 Aerovance
10.9.1 Aerovance Company Information
10.9.2 Aerovance Introduction and Business Overview
10.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Aerovance Devices for Inhaled Medications Products Offered
10.9.5 Aerovance Recent Development
10.10 AstraZeneca
10.10.1 AstraZeneca Company Information
10.10.2 AstraZeneca Introduction and Business Overview
10.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AstraZeneca Devices for Inhaled Medications Products Offered
10.10.5 AstraZeneca Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Information
10.11.2 Boehringer Ingelheim Introduction and Business Overview
10.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Boehringer Ingelheim Devices for Inhaled Medications Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Chiesi
10.12.1 Chiesi Company Information
10.12.2 Chiesi Introduction and Business Overview
10.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Chiesi Devices for Inhaled Medications Products Offered
10.12.5 Chiesi Recent Development
10.13 Cipla
10.13.1 Cipla Company Information
10.13.2 Cipla Introduction and Business Overview
10.13.3 Cipla Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Cipla Devices for Inhaled Medications Products Offered
10.13.5 Cipla Recent Development
10.14 Civitas/Alkermes
10.14.1 Civitas/Alkermes Company Information
10.14.2 Civitas/Alkermes Introduction and Business Overview
10.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Civitas/Alkermes Devices for Inhaled Medications Products Offered
10.14.5 Civitas/Alkermes Recent Development
10.15 GlaxoSmithKline
10.15.1 GlaxoSmithKline Company Information
10.15.2 GlaxoSmithKline Introduction and Business Overview
10.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.15.4 GlaxoSmithKline Devices for Inhaled Medications Products Offered
10.15.5 GlaxoSmithKline Recent Development
10.16 Hovione
10.16.1 Hovione Company Information
10.16.2 Hovione Introduction and Business Overview
10.16.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Hovione Devices for Inhaled Medications Products Offered
10.16.5 Hovione Recent Development
10.17 Mannkind
10.17.1 Mannkind Company Information
10.17.2 Mannkind Introduction and Business Overview
10.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Mannkind Devices for Inhaled Medications Products Offered
10.17.5 Mannkind Recent Development
10.18 Mantecorp
10.18.1 Mantecorp Company Information
10.18.2 Mantecorp Introduction and Business Overview
10.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Mantecorp Devices for Inhaled Medications Products Offered
10.18.5 Mantecorp Recent Development
10.19 Meda
10.19.1 Meda Company Information
10.19.2 Meda Introduction and Business Overview
10.19.3 Meda Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Meda Devices for Inhaled Medications Products Offered
10.19.5 Meda Recent Development
10.20 MicroDose Therapeutx
10.20.1 MicroDose Therapeutx Company Information
10.20.2 MicroDose Therapeutx Introduction and Business Overview
10.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.20.4 MicroDose Therapeutx Devices for Inhaled Medications Products Offered
10.20.5 MicroDose Therapeutx Recent Development
10.21 Novartis
10.21.1 Novartis Company Information
10.21.2 Novartis Introduction and Business Overview
10.21.3 Novartis Devices for Inhaled Medications Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Novartis Devices for Inhaled Medications Products Offered
10.21.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Devices for Inhaled Medications Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Devices for Inhaled Medications Industrial Chain Analysis
11.4 Devices for Inhaled Medications Market Dynamics
11.4.1 Devices for Inhaled Medications Industry Trends
11.4.2 Devices for Inhaled Medications Market Drivers
11.4.3 Devices for Inhaled Medications Market Challenges
11.4.4 Devices for Inhaled Medications Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Devices for Inhaled Medications Distributors
12.3 Devices for Inhaled Medications Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock